4JLR
Crystal structure of a designed Respiratory Syncytial Virus Immunogen in complex with Motavizumab
Summary for 4JLR
Entry DOI | 10.2210/pdb4jlr/pdb |
Descriptor | Motavizumab Fab heavy chain, Motavizumab Fab light chain, RSV_1Isea designed scaffold, ... (5 entities in total) |
Functional Keywords | antibody, designed immunogen, specific binding, rsv f protein, immune system |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 6 |
Total formula weight | 123777.45 |
Authors | Rupert, P.B.,Correia, B.,Schief, W.,Strong, R.K. (deposition date: 2013-03-12, release date: 2014-02-05, Last modification date: 2014-12-17) |
Primary citation | Correia, B.E.,Bates, J.T.,Loomis, R.J.,Baneyx, G.,Carrico, C.,Jardine, J.G.,Rupert, P.,Correnti, C.,Kalyuzhniy, O.,Vittal, V.,Connell, M.J.,Stevens, E.,Schroeter, A.,Chen, M.,Macpherson, S.,Serra, A.M.,Adachi, Y.,Holmes, M.A.,Li, Y.,Klevit, R.E.,Graham, B.S.,Wyatt, R.T.,Baker, D.,Strong, R.K.,Crowe, J.E.,Johnson, P.R.,Schief, W.R. Proof of principle for epitope-focused vaccine design. Nature, 507:201-206, 2014 Cited by PubMed: 24499818DOI: 10.1038/nature12966 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.71 Å) |
Structure validation
Download full validation report